Latest Articles
Acrivon Therapeutics: Endometrial Cancer Data Continues To Justify A Nascent Thesis - Seeking Alpha
Acrivon Therapeutics: Endometrial Cancer Data Continues To Justify A Nascent Thesis Seeking Alpha
Published: Dec. 12, 2024, 8:25 p.m.
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update comes in li - Defense World
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update …
Published: Dec. 4, 2024, 8:10 a.m.
Karyopharm Therapeutics Provides Endometrial Cancer Program Update - Investor Relations | Karyopharm Therapeutics
Karyopharm Therapeutics Provides Endometrial Cancer Program Update Investor Relations | Karyopharm Therapeutics
Published: Dec. 3, 2024, 12:01 p.m.
Karyopharm Therapeutics Provides Endometrial Cancer Program Update - Kilgore News Herald
Karyopharm Therapeutics Provides Endometrial Cancer Program Update Kilgore News Herald
Published: Dec. 3, 2024, noon
Karyopharm Therapeutics Provides Endometrial Cancer Program Update - PR Newswire
Karyopharm Therapeutics Provides Endometrial Cancer Program Update PR Newswire
Published: Dec. 3, 2024, noon
Karyopharm Therapeutics Provides Endometrial Cancer Program Update - Longview News-Journal
Karyopharm Therapeutics Provides Endometrial Cancer Program Update Longview News-Journal
Published: Dec. 3, 2024, noon
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships - Proactive Investors UK
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships Proactive Investors UK
Published: Nov. 14, 2024, 4:39 p.m.
Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights GlobeNewswire
Published: Nov. 13, 2024, 12:15 p.m.
Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update The Manila Times
Published: Nov. 12, 2024, 9:12 p.m.
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - The Manila Times
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results The Manila Times
Published: Nov. 7, 2024, 12:14 p.m.
Link copied to clipboard!